This inventor holds 3 USPTO granted patents. Top assignee: Mereo Biopharma 1 Limited. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide you with an article about the inventor Colm Farrell.
Title: The Innovations of Colm Farrell: Pioneering Dosage Regimens for Chronic Conditions
Introduction:
Colm Farrell, a visionary inventor based in London, GB, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of three patents, his groundbreaking work has revolutionized the treatment of chronic conditions.
Latest Patents:
Colm Farrell's latest patents include Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease and Dosage regimen for the treatment of acute exacerbations of inflammatory conditions. These inventions focus on the innovative use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or its derivatives in managing acute exacerbations of various chronic and inflammatory conditions.
Career Highlights:
Colm Farrell is currently associated with Mereo Biopharma 1 Limited, a leading pharmaceutical company at the forefront of medical advancements. His role within the company showcases his commitment to driving innovation and improving patient outcomes in the healthcare sector.
Collaborations:
Throughout his career, Colm Farrell has collaborated with esteemed colleagues such as Colin Orford and Cyril Clarke. These collaborations have led to synergistic advancements in pharmaceutical research and development, further solidifying his standing as a key figure in the field.
Conclusion:
In conclusion, Colm Farrell's inventive genius and unwavering commitment to innovation continue to inspire and shape the future of technology. His remarkable contributions have left an indelible mark on the industry, solidifying his legacy as a true visionary in the world of inventions. It is clear that Colm Farrell's pioneering work will continue to drive progress in the field of pharmaceuticals, benefiting countless individuals worldwide.
If you have any more specific requests or need further information about Colm Farrell or any other innovator, feel free to ask!
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile